CONNECT BIOPHARMA HOLDINGS L
CNTB · NASDAQ
Updated at 2026-10-14 09:20:46
- Today's High
- $0.93
- Today’s Low
- $0.87
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.90
- Previous Close
- $0.90
- Volume
- 1.61M
- Market Cap
- $57.03M
- P/E Ratio
- --
- EPS
- $-1.19
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3580 CARMEL MOUNTAIN ROAD, SAN DIEGO, CA, UNITED STATES, 92130
- Country
- US
- Listing Date
- 2021-03-19
- Fiscal Year End
- December
- Shares Outstanding
- 62.96M
- CIK
- 0001835268
- Website
- www.connectbiopharm.com
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators for the treatment of severe autoimmune diseases and inflammation. The company is headquartered in Taicang, China.
Financial Metrics
Revenue
2026-06-30
$2.93M
2026-03-31
$169K
2025-12-31
$16K
2025-09-30
$16K
Operating Expenses
2026-06-30
$40.14M
2026-03-31
$19.77M
2025-12-31
$15.52M
2025-09-30
$17.69M
Net Income
2026-06-30
-$36.68M
2026-03-31
-$19.39M
2025-12-31
-$15.1M
2025-09-30
-$17.2M
Net Profit Margin
2026-06-30
-1.24K%
2026-03-31
-11.47K%
2025-12-31
-94.43K%
2025-09-30
-107.5K%
Earnings Per Share
2026-06-30
$-0.27
2026-03-31
$-0.26
2025-12-31
$-0.27
2025-09-30
$-0.31
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$36.88M
2026-03-31
-$19.44M
2025-12-31
-$14.9M
2025-09-30
-$17.49M
Effective Tax Rate
2026-06-30
-0.29%
2026-03-31
--
2025-12-31
-0.17%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $2.93M | $169K | $16K | $16K |
| Operating Expenses | $40.14M | $19.77M | $15.52M | $17.69M |
| Net Income | -$36.68M | -$19.39M | -$15.1M | -$17.2M |
| Net Profit Margin | -1.24K% | -11.47K% | -94.43K% | -107.5K% |
| Earnings Per Share | $-0.27 | $-0.26 | $-0.27 | $-0.31 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$36.88M | -$19.44M | -$14.9M | -$17.49M |
| Effective Tax Rate | -0.29% | -- | -0.17% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.